• 1
    MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 22132.
  • 2
    Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J 1981; 282: 2636.
  • 3
    Poynard T, Aubert A, Bedossa P, et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991; 100: 1397402.
  • 4
    Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25: 10811.
  • 5
    Naveau S, Raynard B, Ratziu V, et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005; 3: 16774.
  • 6
    Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 137381.
  • 7
    Graudal N, Leth P, Marbjerg L, Galloe AM. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J Intern Med 1991; 230: 16571.
  • 8
    Diehl AM. Liver disease in alcoholic abusers: clinical perspective. Alcohol 2002; 27: 711.
  • 9
    Gordon H. Detection of alcoholic liver disease. World J Gastroenterol 2001; 7: 297302.
  • 10
    Menon KV, Gores GJ, Shah VH. Pathogenesis, diagnosis and treatment of alcoholic liver disease. Mayo Clin Proc 2001; 76: 10219.
  • 11
    Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the French association for the study of the liver (AFEF). Hepatology 2000; 32: 47781.
  • 12
    Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14: 5438.
  • 13
    Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin in hepatic fibrosis. Diagnostic interest. Dig Dis Sci 1994; 39: 242632.
  • 14
    Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 160916.
  • 15
    Tran A, Hastier P, Barjoan EM, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000; 24: 62630.
  • 16
    Wai CT, Greenson JK, Fontana RJ, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 51826.
  • 17
    Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study. Lancet 2001; 357: 106975.
  • 18
    Adams LA, Bulsara M, Rossi E, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 186773.
  • 19
    Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 170513.
  • 20
    Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 4854.
  • 21
    Saito H, Tada S, Nakamoto N, et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 2004; 29: 97103.
  • 22
    Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 34350.
  • 23
    Melin P, Dacon A, Gauchet A, Schoeny M, Diebold MD. Fibroscan for cirrhosis diagnosis in heavy drinkers [abstract]. Gastroenterol Clin Biol 2005; 29: A144.
  • 24
    Nousbaum JB, Cadranel JF, Bonnemaison G, et al. Clinical practice guidelines on the use of liver biopsy. Gastroenterol Clin Biol 2002; 26: 84878.
  • 25
    Konate A, Reaud S, Quemener E, Fouchard-Hubert I, Oberti F, Cales P. Liver stiffness measurement (LSM) by transient elastography: predictive factors of accuray, success and reproducibility [abstract]. J Hepatol 2006; 44: S195.
  • 26
    Bedossa P, Poynard T. An algorithm for grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 28993.
  • 27
    Michalak S, Rousselet MC, Bedossa P, et al. Respective roles of porto-septal fibrosis and centrolobular fibrosis in alcoholic liver disease. J Pathol 2003; 201: 5562.
  • 28
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 246774.
    Direct Link:
  • 29
    Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12: 1738.
  • 30
    Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 1939.
  • 31
    Hanley J, McNeil B. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 83943.
  • 32
    Kawamoto M, Mizuguchi T, Katsuramaki T, et al. Assessment of liver fibrosis by a non invasive method of transient elastography and biochemical markers. World J Gastroenterol 2006; 12: 432530.
  • 33
    Ziol M, Barget N, Bourcier V, Garnier T, Beaugrand M. Amount and type of liver fibrosis detected by stiffness measurements [abstract]. Hepatology 2005; 42(Suppl. 1): 341A.
  • 34
    Marcellin P, De Ledinghen V, Dhumeaux D, et al. Non-invasive diagnosis of liver fibrosis in chronic viral hepatitis B by Fibroscan [abstract]. Gastroenterol Clin Biol 2005; 29: 895.
  • 35
    De Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus – coinfected patients. J Acquir Immune Defic Syndr 2006; 41: 1759.
  • 36
    Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 111824.
  • 37
    Pares A, Caballeria E, Lazaro E, Garcia-Criado A, Navasa M, Gilabert R. Transient elastography: a new and useful non-invasive methode for assessing liver damage progression in primary biliary cirrhosis [abstract]. Hepatology 2005; 42(Suppl. 1): A464.
  • 38
    De Ledinghen V, Beaugrand M, Kelleher TB, et al. Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): risk factors and diagnostic potential of liver elasticicty using Fibroscan [abstract]. J Hepatol 2006; 44(Suppl. 2): S39.
  • 39
    Foucher J, Chanteloup E, Castera L, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 4038.
  • 40
    Ganne-Carrie N, Ziol M, De Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 15117.
  • 41
    Kazemi F, Kettaneh A, N’kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 2305.
  • 42
    Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 3718.
  • 43
    Nguyen-Khac E, Capron D, Braillon A, Dupas JL. The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs. Gut 2008; in press.
  • 44
    Foucher J, Castera L, Bernard PH, et al. Assessment of cirrhosis and its severity by Fibroscan and biochemical markers in alcoholic patients [abstract]. J Hepatol 2006; 44(Suppl. 2): S39.
  • 45
    Nahon P, Ziol M, De Ledinghen V, et al. Assessment of liver fibrosis using liver stiffness measurement (LSM) in patients with alcoholic liver disease [abstract]. J Hepatol 2007; 46(Suppl. 1): S278.
  • 46
    Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate Aminotransferase to platelet ratio index in patients with alcoholic liver disease. Am J Gastroenterol 2006; 101: 15008.
    Direct Link:
  • 47
    Anty R, Vanbiervliet G, Gelsi E, et al. Independent assessment of non-invasive biological tests for liver fibrosis (Fibrometer, Hepascore, APRI) in alcoholic liver disease [abstract]. Gastroenterol Clin Biol 2006; 30: 1057.
  • 48
    Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495500.
  • 49
    Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 23944.
  • 50
    Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 144957.
  • 51
    Mathurin P, Beuzin F, Louvet A, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007; 25: 104754.
  • 52
    Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20: 34955.
  • 53
    Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 114771.
  • 54
    Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007; 46: 62834.
  • 55
    Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 26148.
    Direct Link:
  • 56
    Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003; 38: 42732.
  • 57
    Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 4112.